When myopathy strikes in a cancer patient

Gastrointestinal Cancer Research

Volumn 3, Issue 5, 2009, Pages 212-214

  Gopaluni, Srivalli ^a   Thomas, Lilian M ^a   Shah, Chirag ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ANTINUCLEAR ANTIBODY; C REACTIVE PROTEIN; CAPECITABINE; CARCINOEMBRYONIC ANTIGEN; CREATINE KINASE; FLUOROURACIL; FOLINIC ACID; HISTIDINE TRANSFER RNA LIGASE; OXALIPLATIN; PREDNISONE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CANCER ADJUVANT THERAPY; CANCER PATIENT; CASE REPORT; COLON ADENOCARCINOMA; DELTOID MUSCLE; DERMATOMYOSITIS; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG WITHDRAWAL; ELECTROMYOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FIBROMYALGIA; HEMATOCRIT; HEMICOLECTOMY; HEMOGLOBIN BLOOD LEVEL; HUMAN; LEUKOCYTE COUNT; MACULOPAPULAR RASH; MULTIPLE CYCLE TREATMENT; MUSCLE BIOPSY; MUSCLE STRENGTH; MUSCLE WEAKNESS; MYOPATHY; NERVE CONDUCTION; NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOARTHRITIS; PRURITUS; QUADRICEPS FEMORIS MUSCLE; SIDE EFFECT; THROMBOCYTE COUNT; TIBIALIS ANTERIOR MUSCLE; TREATMENT OUTCOME;

EID: 77953379055     PISSN: 19347820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Callen JP: Dermatomyositis. Lancet 355:53-57, 2000
2. Hill CL, Zhang Y, Sigurgeirsson B, et al: Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study: Lancet 357:96-100, 2001
3. Callen JP, Wortmann RL: Dermatomyositis. Clin Dermatol 24(5):363-373, 2006
4. Buchbinder R, Forbes A, Hall S, et al: Incidence of malignant disease in biopsy-proven inflammatory myopathy. a population-based cohort study. Ann Intern Med 134(12):1087-1095, 2001
5. Sparsa A, Liozon E, Herrmann F, et al: Routine vs extensive malignancy search for adult dermatomyositis and polymyositis. Arch Dermatol 138:885-889, 2002
6. Levin SM: Cancer and myositis: new insights into an old association. Curr Opin Rheumatol 18:620-624, 2006
7. Siguregeirsson B, Lindelof B, Edhag O, et al: Risk of cancer in patients with dermatomyositis or polymyositis. N Engl J Med 325:363-367, 1992
8. Manchul LA, Jin A, Pritchard KI, et al: The frequency of malignant neoplasm in patients with polymyositis-dermatomyositis. A controlled study. Arch Intern Med 145:1835-1839, 1985
9. Lakhanpal S, Bunch TW, Ilstrup DM, et al: Polymyosits-dermatoyositis and malignant lesions: does an association exist? Mayo Clin Proc 61:645-653, 1986
10. Yazici Y, Kagen LJ: The association of malignancy with myositis. Curr Opin Rheumatol 12:498-500, 2000
11. Callen JP: Dermatomyositis and malignancy. Clin Rheum Dis 8:369-381, 1982
12. Hill CL, Zhang Y, Sigurgeirsson B, et al: Frequency of cancer types in dermatomyositis and polymyositis: a population based study. Lancet 357: 96-100, 2001
13. Whitmore SE, Rosenshein NB, Provost TT: Ovarian cancer in patients with dermatomyositis. Medicine (Baltimore) 73:153-160, 1994
14. Airio A, Pukkala E, Isomäki H: Elevated cancer incidence in patients with dermatomyositis: a population-based study. J Rheumatol 22:1300-1303, 1995
15. Zantos D, Zhang Y, Felson D: The overall and temporal association of cancer with polymyositis and dermatomyositis. J Rheumatol 21:1855-1859, 1994
16. Verducci MA, Malkasian GD, Friedman SJ, et al: Gynecologic carcinoma associated with dermatomyositis-polymyositis. Obstet Gynecol 64:695-698, 1984
17. Sunnenberg TD, Kitchens CS: Dermatomyositis associated with malignant melanoma: a parallel occurrence, remission and relapse of the two processes in a patient. Cancer 51:2157-2158, 1983
18. Bonnetblanc JM, Bernard P, Fayol J: Dermatomyositis and malignancy: a multicenter cooperative study. Dermatologica 180:212-216, 1990
19. Hidano A, Kaneko K, Arai Y, et al: Survey of the prognosis of dermatomyositis with special reference to its association with malignancy and pulmonary fibrosis. J Dermatol 13:233-241, 1986
20. Lotz BP, Engel AG, Nishino H, et al: Inclusion body myositis. observations in 40 patients. Brain 112:727-747, 1989
21. Barnes BE: Dermatomyositis and malignancy: a review of the literature. Ann Intern Med 84:68-76, 1976
22. Hidano A, Kaneko K, Arai Y, et al: Survey of the prognosis for dermatomyositis, with special reference to its association with malignancy and pulmonary fibrosis. J Dermatol 13:233-241, 1986
23. Wakata N, Kurihara T, Saito E, et al: Polymyositis and dermatomyositis associated with malignancy: a 30-year retrospective study. Int J Dermatol 41(11):729-734, 2002
24. Callen JP: The value of malignancy evaluation in patients with dermatomyositis. J Am Acad Dermatol 6:253-259, 1982
25. Whitmore SE, Watson R, Rosenshein NB, et al: Dermatomyositis sine myositis: association with malignancy. J Rheumatol 23:101-105, 1996
26. Callen JP: When and how should the patient with dermatomyositis or amyopathic dermatomyositis be assessed for possible cancer? Arch Dermatol 138(7):969-971, 2002
27. Scaling ST, Kaufman RH, Patten BM: Dermatomyositis and female malignancy. Obstet Gynecol 54:474-477, 1979
28. Hill CL, Zhang Y, Sigurgeirsson B, et al: Frequency of cancer types in dermatomyositis and polymyositis: a population based study. Lancet 357:96-100, 2001
29. Marie I, Hatron PY, Levesque H, et al: Influence of age on characteristics of polymyositis and dermatomyositis in adults. Medicine (Baltimore) 78: 139-147, 1999
30. Pautas E, Cherin P, Piette JC, et al: Features of polymyositis and derma - tomyositis in elderly: a case control study. Clin Exp Rheumatol 18:241-244, 2000